Elevation Oncology, Inc. – NASDAQ:ELEV
Founder-led company
Elevation Oncology stock price today
$0.377
-0.21
-36.5%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 3 hours
Elevation Oncology stock price monthly change
-79.38%
month
Elevation Oncology stock price quarterly change
-79.38%
quarter
Elevation Oncology stock price yearly change
+8.20%
year
Elevation Oncology key metrics
Market Cap | 33.57M |
Enterprise value | 31.21M |
P/E | -0.47 |
EV/Sales | N/A |
EV/EBITDA | -0.32 |
Price/Sales | N/A |
Price/Book | 0.97 |
PEG ratio | N/A |
EPS | -1.04 |
Revenue | N/A |
EBITDA | -38.53M |
Income | -39.35M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeElevation Oncology stock price history
Elevation Oncology stock forecast
Elevation Oncology financial statements
| Jun 2023 | 0 | -10.11M | |
|---|---|---|---|
| Sep 2023 | 0 | -10.63M | |
| Dec 2023 | 58K | -7.89M | -13618.97% |
| Mar 2024 | 0 | -10.70M |
| Mar 2024 | 0 | -10.70M | |
|---|---|---|---|
| Sep 2025 | 0 | -8.48M | |
| Oct 2025 | 0 | -11.30M | |
| Dec 2025 | 0 | -11.85M |
Analysts Price target
Financials & Ratios estimates
| 2022-08-04 | -0.93886 | -0.86 |
|---|---|---|
| 2022-11-03 | -2.14862 | -1.67 |
| 2023-03-09 | -0.86043 | -0.82 |
| Jun 2023 | 110370000 | 38.18M | 34.6% |
|---|---|---|---|
| Sep 2023 | 99975000 | 37.55M | 37.57% |
| Dec 2023 | 89091000 | 34.28M | 38.48% |
| Mar 2024 | 108961000 | 33.14M | 30.42% |
| Jun 2023 | -13.81M | 16.5M | 47.73M |
|---|---|---|---|
| Sep 2023 | -13.35M | -38.11M | 27K |
| Dec 2023 | -12.18M | 6.56M | -2K |
| Mar 2024 | -9.57M | 20.7M | 30.25M |
Elevation Oncology alternative data
| Aug 2023 | 33 |
|---|---|
| Sep 2023 | 33 |
| Oct 2023 | 33 |
| Nov 2023 | 33 |
| Dec 2023 | 33 |
| Jan 2024 | 33 |
| Feb 2024 | 33 |
| Mar 2024 | 29 |
| Apr 2024 | 29 |
| May 2024 | 29 |
| Jun 2024 | 29 |
| Jul 2024 | 29 |
Elevation Oncology other data
26.71%
-35.22%
of ELEV is owned by hedge funds
6.21M
-8.20M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2021 | 1625000 | 0 |
| May 2022 | 0 | 702737 |
| Insider | Compensation |
|---|---|
Dr. Shawn M. Leland Pharm.D., R.Ph. (1984) Founder, Pres, Chief Executive Officer & Director | $452,740 |
-
What's the price of Elevation Oncology stock today?
One share of Elevation Oncology stock can currently be purchased for approximately $0.38.
-
When is Elevation Oncology's next earnings date?
Unfortunately, Elevation Oncology's (ELEV) next earnings date is currently unknown.
-
Does Elevation Oncology pay dividends?
No, Elevation Oncology does not pay dividends.
-
How much money does Elevation Oncology make?
Elevation Oncology has a market capitalization of 33.57M. Elevation Oncology made a loss 45.7M US dollars in net income (profit) last year or -$0.82 on an earnings per share basis.
-
What is Elevation Oncology's stock symbol?
Elevation Oncology, Inc. is traded on the NASDAQ under the ticker symbol "ELEV".
-
What is Elevation Oncology's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Elevation Oncology?
Shares of Elevation Oncology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Elevation Oncology's key executives?
Elevation Oncology's management team includes the following people:
- Dr. Shawn M. Leland Pharm.D., R.Ph. Founder, Pres, Chief Executive Officer & Director(age: 41, pay: $452,740)
-
Is Elevation Oncology founder-led company?
Yes, Elevation Oncology is a company led by its founder Dr. Shawn M. Leland Pharm.D., R.Ph..
-
How many employees does Elevation Oncology have?
As Jul 2024, Elevation Oncology employs 29 workers.
-
When Elevation Oncology went public?
Elevation Oncology, Inc. is publicly traded company for more then 4 years since IPO on 25 Jun 2021.
-
What is Elevation Oncology's official website?
The official website for Elevation Oncology is elevationoncology.com.
-
Where are Elevation Oncology's headquarters?
Elevation Oncology is headquartered at 888 Seventh Avenue, New York, NY.
-
How can i contact Elevation Oncology?
Elevation Oncology's mailing address is 888 Seventh Avenue, New York, NY and company can be reached via phone at +7 163711125.
Elevation Oncology company profile:
Elevation Oncology, Inc.
elevationoncology.comExchange:
NASDAQ
Full time employees:
29
Industry:
Biotechnology
Sector:
Healthcare
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.
888 Seventh Avenue
New York, NY 10106
New York, NY 10106
CIK: 0001783032
ISIN: US28623U1016
CUSIP: 28623U101
